Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;46(6):2264-2280.
doi: 10.1007/s00261-021-03081-0. Epub 2021 Jun 5.

Current update on malignant epithelial ovarian tumors

Sherif B Elsherif  1   2 , Priya R Bhosale  3 , Chandana Lall  4 , Christine O Menias  5 , Malak Itani  6 , Kristina A Butler  7 , Dhakshinamoorthy Ganeshan  3
Affiliations
Review

Current update on malignant epithelial ovarian tumors

Sherif B Elsherif et al. Abdom Radiol (NY). 2021 Jun.

Abstract

Epithelial ovarian cancer (EOC) represents the most frequently occurring gynecological malignancy, accounting for more than 70% of ovarian cancer deaths. Preoperative imaging plays an important role in assessing the extent of disease and guides the next step in surgical decision-making and operative planning. In this article, we will review the multimodality imaging features of various subtypes of EOC. We will also discuss the role of imaging in the staging, management, and surveillance of EOC.

Keywords: Endometrioid carcinoma; Epithelial ovarian cancer; High-grade serous ovarian cancer; Low-grade serous ovarian cancer; Magnetic resonance imaging; Ovarian neoplasms.

PubMed Disclaimer

References

    1. Liu D, Zhang L, Indima N, Peng K, Li Q, Hua T, Tang G (2017) CT and MRI findings of type I and type II epithelial ovarian cancer. European Journal of Radiology 90:225–233. https://doi.org/10.1016/j.ejrad.2017.02.017 - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68 (6):394–424 - DOI - PubMed
    1. Signorelli M, Guerra L, Pirovano C, Crivellaro C, Fruscio R, Buda A, Cuzzucrea M, Elisei F, Ceppi L, Messa C (2013) Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study. Gynecol Oncol 131 (2):395–399. https://doi.org/10.1016/j.ygyno.2013.08.022 - DOI - PubMed
    1. Eoh KJ, Park HS, Park JS, Lee ST, Han J, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ (2017) Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients. Cancer Res Treat 49 (2):408–415. https://doi.org/10.4143/crt.2016.135 - DOI - PubMed
    1. Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande PV, Salazar GM, Shipp TD, Simpson L, Small W, Jr., Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P (2018) ACR Appropriateness Criteria(®) Staging and Follow-Up of Ovarian Cancer. Journal of the American College of Radiology: JACR 15 (5s):S198–S207. https://doi.org/10.1016/j.jacr.2018.03.015 - DOI - PubMed

MeSH terms

LinkOut - more resources